PH027-1 (WRN Inhibitor)
Likely MSI-High Cancers
IND ApprovedPre-Phase 1
Key Facts
About Puhe Biopharma
A China-based biotech developing AI-driven small-molecule drugs for cancer and immune disorders with a global-first-tier pipeline.
View full company profile